StockData

OrthoPediatrics vs Si-Bone

KIDS and SIBN side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How KIDS and SIBN compare

Si-Bone is the larger company, worth 1.3 times as much as OrthoPediatrics ($1.0B against $820M).

OrthoPediatrics grew revenue faster over the last twelve months (16.1% versus 15.3% for Si-Bone).

Si-Bone keeps more of each dollar of sales as profit, with a net margin of −6.9% compared with −12.8% at OrthoPediatrics.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricKIDSSIBN
Size and price
Market cap$820M$1.0B
Share price$31.41$23.16
Change, 1 year88.0%33.0%
Change, 5 years−46.0%15.7%
Beta (5Y)0.690.31
Employees602376
StockData Score
Total score1111
Valuation score2 (better)0
Growth score44
Performance score33
Health score24 (better)
Dividend score00
Valuation
P/S3.1× (better)4.9×
P/B2.4× (better)5.7×
P/FCF258×–
FCF yield0.39% (better)−0.42%
Fair value$34.15$16.33
Margin of safety8.0% (better)−41.8%
Growth
Revenue growth (TTM)16.1% (better)15.3%
Revenue growth, 5Y average27.2% (better)22.3%
Profitability
Gross margin73.8%79.5% (better)
Operating margin−9.4%−8.3% (better)
Net margin−12.8%−6.9% (better)
FCF margin1.2% (better)−2.1%
Return on equity−9.8%−8.3% (better)
Return on invested capital−5.0% (better)−19.6%
Financial health
Debt / equity0.300.20 (better)
Interest coverage−2.7× (better)−7.1×
Current ratio4.559.15 (better)
Altman Z-score2.908.36 (better)
Piotroski F-score46 (better)
Dividends and buybacks
Dividend yield–0.00%
Years of dividend growth–0
Shareholder yield0.00%0.00%
Ownership
Held by institutions64.3%108%
Held by insiders30.2%3.7%
Insider net buying, 12 months−$47.8M−$14.6M (better)
Short interest, % of float4.1%10.5%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.